Global /Taiwan /Healthcare /Biotechnology /6926

Shine-On BioMedical Co.,Ltd.

6926

• TPEX: 6926 • Delayed

66.00TWD 2.8%

2.09 USD

As of 21 June 2026, Shine-On BioMedical Co.,Ltd. has a market cap of $101.11M USD, ranking #25474 globally and #1378 in Taiwan. It ranks #2281 in the Healthcare sector, and #438 in the Biotechnology industry.

Global Rank

25474

Country Rank

1378

Sector Rank

2281

Industry Rank

438

Key Stats

Market Cap

$101.11MUSD

3.2B TWD

Enterprise Value

$71.95MUSD

2.28B TWD

Revenue (TTM)

$948.72KUSD

30.0M TWD

EBITDA (TTM)

-$3.9MUSD

-123.43M TWD

Net Income (TTM)

-$3.49MUSD

-110.29M TWD

PS Ratio

106.6

PB Ratio

3.5

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Biotechnology

CEO

Hongzhe Jiang open_in_new

Employees

Founded

2011

Website

shineon-bio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.8%	-2.4%	-4.5%	-8.5%	-12%	-8.3%	1.1%	-4.9%	40%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6926 聖安生醫股份有限公司 Ordinary Shares ISIN: TW0006926009 Shares Out.: Shares Outstanding: 49.8M¹ TV: TradingView: TPEX: 6926 SA: Stock Analysis: TPEX: 6926 YF: Yahoo Finance: 6926.TWO GF: Google Finance: TPEX: 6926 BA: Barron's: 6926 MS: Morningstar: ROCO: 6926	66.00 TWD	TV: TradingView: TPEX: 6926 SA: Stock Analysis: TPEX: 6926 YF: Yahoo Finance: 6926.TWO GF: Google Finance: TPEX: 6926 BA: Barron's: 6926 MS: Morningstar: ROCO: 6926

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Caliway Biopharmaceuticals Co., Ltd. TWSE: 6919	$5.46B 172.76B TWD 5K%	-	Taiwan
Pell Bio-Med Technology Co., Ltd. TWSE: 6949	$1.61B 50.93B TWD 1K%	-	Taiwan
Lin BioScience, Inc. TPEX: 6696	$1.08B 34.04B TWD 965%	-	Taiwan
HanchorBio Inc. TWSE: 7827	$726.25M 22.97B TWD 618%	-	Taiwan
HanchorBio Inc. TPEX: 7827	$600.25M 18.98B TWD 494%	-	Taiwan
Locus Cell Co., Ltd. TPEX: 06891	$571.26M 18.06B TWD 465%	-	Taiwan

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 180K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 158K%	19.0	United States
argenx SE EBR: ARGX	$47.43B 41.39B EUR 47K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.23B 68.19T KRW 44K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.27B 60.27B AUD 42K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.88B 33.71B CHF 41K%	37.2	Switzerland

chevron_leftBack